Indication
Alveolar soft part sarcoma
Alveolar soft part sarcoma is an exceedingly rare, indolent, but clinically aggressive malignant neoplasm of soft tissue that most commonly affects adolescents and young adults. Read more about Alveolar soft part sarcoma
2 drugs 1 manufacturers
Drugs that treat it
Common Alveolar soft part sarcoma therapies.
TECENTRIQ HYBREZA (atezolizumab-hyaluronidase-tqjs)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAlveolar soft part sarcoma is an exceedingly rare, indolent, but clinically aggressive malignant neoplasm of soft tissue that most commonly affects adolescents and young adults.
It classically arises within the deep connective tissues or skeletal muscles of the extremities—predominantly the lower limbs—in adults, while frequently presenting in the head and neck region, particularly the orbit or tongue, in children.
Pathophysiologically, it is defined by an unbalanced translocation, der(17)t(X;17)(p11.2;q25), which creates the pathogenic *ASPSCR1–TFE3* gene fusion and leads to dysregulated transcription.
Histopathologically, tumors demonstrate organoid or nested pseudoalveolar architectures of large cells accompanied by prominent vascularity, predisposing patients to early hematogenous metastases, most commonly to the lungs, brain, and bones.
- cancer.gov
Alveolar soft part sarcoma is an exceedingly rare, indolent, but clinically aggressive malignant neoplasm of soft tissue that most commonly affects adolescents and young adults It classically arises within the deep connective tissues or skeletal muscles of the extremities—predominantly the lower limbs—in adults, while frequently presenting in the head and neck region, particularly the orbit or tongue, in children Histopathologically, tumors demonstrate organoid or nested pseudoalveolar architect...
- nih.gov
Alveolar soft part sarcoma is an exceedingly rare, indolent, but clinically aggressive malignant neoplasm of soft tissue that most commonly affects adolescents and young adults Histopathologically, tumors demonstrate organoid or nested pseudoalveolar architectures of large cells accompanied by prominent vascularity, predisposing patients to early hematogenous metastases, most commonly to the lungs, brain, and bones
- nih.gov
It classically arises within the deep connective tissues or skeletal muscles of the extremities—predominantly the lower limbs—in adults, while frequently presenting in the head and neck region, particularly the orbit or tongue, in children Pathophysiologically, it is defined by an unbalanced translocation, der(17)t(X;17)(p11.2;q25), which creates the pathogenic *ASPSCR1–TFE3* gene fusion and leads to dysregulated transcription
- rarediseases.org
Pathophysiologically, it is defined by an unbalanced translocation, der(17)t(X;17)(p11.2;q25), which creates the pathogenic *ASPSCR1–TFE3* gene fusion and leads to dysregulated transcription Histopathologically, tumors demonstrate organoid or nested pseudoalveolar architectures of large cells accompanied by prominent vascularity, predisposing patients to early hematogenous metastases, most commonly to the lungs, brain, and bones
Personalize your experience
Follow Alveolar soft part sarcoma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.